4.8 Article

Oxalyl Boronates Enable Modular Synthesis of Bioactive Imidazoles

期刊

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
卷 56, 期 22, 页码 6264-6267

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201611006

关键词

biological activity; boron; cross-coupling; heterocycles; synthetic methods

资金

  1. Natural Science and Engineering Research Council (NSERC)
  2. Canadian Institute of Health Research (CIHR)
  3. Astex Pharmaceuticals
  4. Canadian Foundation for Innovation [19119]
  5. Ontario Research Fund
  6. NSERC
  7. Government of Ontario
  8. OGS
  9. AbbVie [1097737]
  10. Bayer Pharma AG
  11. Boehringer Ingelheim
  12. Canada Foundation for Innovation
  13. Eshelman Institute for Innovation
  14. Genome Canada
  15. Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD] [115766]
  16. Janssen
  17. Merck Co.
  18. Novartis Pharma AG
  19. Ontario Ministry of Economic Development and Innovation
  20. Pfizer
  21. Sao Paolo Research Foundation-FAPESP
  22. Takeda
  23. Wellcome Trust [106169/ZZ14/Z]

向作者/读者索取更多资源

Described herein is the preparation of oxalyl boronate building blocks and their application for the construction of heterocycles. The oxalyl unit, readily accessible through commercially available starting materials, enables a modular approach for the synthesis of imidazoles. A variety of aromatic, heteroaromatic, and alkyl carboxaldehydes were condensed with oxalyl boronates to afford substituted boryl imidazoles in a regiocontrolled fashion. Subsequent palladium-catalyzed cross-coupling with haloarenes furnished the desired trisubstituted imidazole scaffolds. To demonstrate the utility of these scaffolds, potent inhibitors of the serine/threonine-protein kinase STK10 were synthesized.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据